Content Library

Revolutionizing Sleep Apnea Care: How Ognomy Won Upstate Capital’s Venture Deal of the Year

Revolutionizing Sleep Apnea Care: How Ognomy Won Upstate Capital’s Venture Deal of the Year

We are excited to highlight Ognomy, the recipient of Upstate Capital’s Annual Awards Venture Deal of the Year. Ognomy is transforming how sleep apnea is diagnosed and treated worldwide, demonstrating a powerful blend of innovation and healthcare impact.

Founded by Dr. Dan Rifkin, Ognomy is the world’s first virtual sleep network, connecting patients directly with sleep specialists through a cutting-edge telemedicine platform. Dr. Rifkin, a practicing physician and CEO, identified a significant gap in global healthcare: while many people lack access to traditional medical care, the widespread use of smartphones offers an opportunity to bridge the gap in sleep apnea care.

This realization led to the creation of Ognomy, allowing for the diagnosis and treatment of sleep apnea entirely via smartphone. This breakthrough makes healthcare accessible even in remote locations, addressing the needs of those who would otherwise go untreated.

Since its launch in 2021, Ognomy has grown rapidly and now serves over 12,000 patients across nearly all 50 states. Its success is a testament to the urgent need for accessible sleep apnea treatment and the effectiveness of its telehealth platform.

David Brown of Impellent Ventures was quick to invest in Ognomy, recognizing its potential for scaling and making a significant impact. Ognomy recently secured a major growth round, further reinforcing investor confidence in its business model and management team.

Noa Simons, President and CEO of Upstate Capital, praised Ognomy’s innovative approach and commended Dr. Rifkin and his team for their profound influence on the healthcare industry. Their work not only addresses a critical health concern but also showcases the power of digital health solutions to transform patient care.

Upstate Capital is proud to support companies like Ognomy, facilitating connections between forward-thinking investors and groundbreaking ventures that are redefining the future of healthcare. Through these connections, we help accelerate the growth of innovative companies that have the potential to change the world.